Leone et al. previously demonstrated that a glutamine blockade by JHU083, a small molecule glutamine antagonist through the inhibition of glutaminase activity, in tumor-bearing mice led to the reduction of hypoxia and the promotion of acidosis of tumor cells, but T cell activation was induced within the tumor microenvironment [29]. The gene discussed is GLS; the disease is neoplasm.